According to our (Global Info Research) latest study, the global Cell and Gene Therapy Solutions market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Cell & gene therapies are used to treat both rare and common diseases. While gene therapy involves the transfer of genetic material, usually within a virus for uptake into diseased cells, cell therapy involves the transfer of genetically altered cells into a patient.
The field of cell and gene therapy is currently in a phase of robust growth, with an expanding market size. As scientific advancements continue, the application scope of cell and gene therapies is widening, encompassing the treatment of various diseases such as cancer, genetic disorders, and autoimmune conditions. Sales within this sector are on a consistent upward trajectory, reflecting significant commercial potential. While some remarkable successes have been achieved in the realm of cell and gene therapy, challenges concerning safety and regulatory compliance persist. Looking ahead, as research deepens, it is anticipated that the field will continue to make breakthroughs, ushering in more innovation and transformative changes within the medical domain.
This report is a detailed and comprehensive analysis for global Cell and Gene Therapy Solutions market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell and Gene Therapy Solutions market size and forecasts, in consumption value ($ Million), 2020-2031
Global Cell and Gene Therapy Solutions market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Cell and Gene Therapy Solutions market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Cell and Gene Therapy Solutions market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy Solutions
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy Solutions market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bluebird Bio, Sarepta Therapeutics, Solid Biosciences, Novartis, Biomarin Pharmaceutical, Uniqure, Spark Therapeutics, Alaunos Therapeutics, Homology Medicines, Biogen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell and Gene Therapy Solutions market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Stem Cell Therapy
Gene Therapy
Other
Market segment by Application
Neurological Diseases
Cancer
Other
Market segment by players, this report covers
Bluebird Bio
Sarepta Therapeutics
Solid Biosciences
Novartis
Biomarin Pharmaceutical
Uniqure
Spark Therapeutics
Alaunos Therapeutics
Homology Medicines
Biogen
Legend Biotech
CARsgen
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Solutions product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Solutions, with revenue, gross margin, and global market share of Cell and Gene Therapy Solutions from 2020 to 2025.
Chapter 3, the Cell and Gene Therapy Solutions competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cell and Gene Therapy Solutions market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Solutions.
Chapter 13, to describe Cell and Gene Therapy Solutions research findings and conclusion.
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Cell and Gene Therapy Solutions by Type
- 1.3.1 Overview: Global Cell and Gene Therapy Solutions Market Size by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Global Cell and Gene Therapy Solutions Consumption Value Market Share by Type in 2024
- 1.3.3 Stem Cell Therapy
- 1.3.4 Gene Therapy
- 1.3.5 Other
- 1.4 Global Cell and Gene Therapy Solutions Market by Application
- 1.4.1 Overview: Global Cell and Gene Therapy Solutions Market Size by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Neurological Diseases
- 1.4.3 Cancer
- 1.4.4 Other
- 1.5 Global Cell and Gene Therapy Solutions Market Size & Forecast
- 1.6 Global Cell and Gene Therapy Solutions Market Size and Forecast by Region
- 1.6.1 Global Cell and Gene Therapy Solutions Market Size by Region: 2020 VS 2024 VS 2031
- 1.6.2 Global Cell and Gene Therapy Solutions Market Size by Region, (2020-2031)
- 1.6.3 North America Cell and Gene Therapy Solutions Market Size and Prospect (2020-2031)
- 1.6.4 Europe Cell and Gene Therapy Solutions Market Size and Prospect (2020-2031)
- 1.6.5 Asia-Pacific Cell and Gene Therapy Solutions Market Size and Prospect (2020-2031)
- 1.6.6 South America Cell and Gene Therapy Solutions Market Size and Prospect (2020-2031)
- 1.6.7 Middle East & Africa Cell and Gene Therapy Solutions Market Size and Prospect (2020-2031)
- 2 Company Profiles
- 2.1 Bluebird Bio
- 2.1.1 Bluebird Bio Details
- 2.1.2 Bluebird Bio Major Business
- 2.1.3 Bluebird Bio Cell and Gene Therapy Solutions Product and Solutions
- 2.1.4 Bluebird Bio Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Bluebird Bio Recent Developments and Future Plans
- 2.2 Sarepta Therapeutics
- 2.2.1 Sarepta Therapeutics Details
- 2.2.2 Sarepta Therapeutics Major Business
- 2.2.3 Sarepta Therapeutics Cell and Gene Therapy Solutions Product and Solutions
- 2.2.4 Sarepta Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Sarepta Therapeutics Recent Developments and Future Plans
- 2.3 Solid Biosciences
- 2.3.1 Solid Biosciences Details
- 2.3.2 Solid Biosciences Major Business
- 2.3.3 Solid Biosciences Cell and Gene Therapy Solutions Product and Solutions
- 2.3.4 Solid Biosciences Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Solid Biosciences Recent Developments and Future Plans
- 2.4 Novartis
- 2.4.1 Novartis Details
- 2.4.2 Novartis Major Business
- 2.4.3 Novartis Cell and Gene Therapy Solutions Product and Solutions
- 2.4.4 Novartis Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Novartis Recent Developments and Future Plans
- 2.5 Biomarin Pharmaceutical
- 2.5.1 Biomarin Pharmaceutical Details
- 2.5.2 Biomarin Pharmaceutical Major Business
- 2.5.3 Biomarin Pharmaceutical Cell and Gene Therapy Solutions Product and Solutions
- 2.5.4 Biomarin Pharmaceutical Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Biomarin Pharmaceutical Recent Developments and Future Plans
- 2.6 Uniqure
- 2.6.1 Uniqure Details
- 2.6.2 Uniqure Major Business
- 2.6.3 Uniqure Cell and Gene Therapy Solutions Product and Solutions
- 2.6.4 Uniqure Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Uniqure Recent Developments and Future Plans
- 2.7 Spark Therapeutics
- 2.7.1 Spark Therapeutics Details
- 2.7.2 Spark Therapeutics Major Business
- 2.7.3 Spark Therapeutics Cell and Gene Therapy Solutions Product and Solutions
- 2.7.4 Spark Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Spark Therapeutics Recent Developments and Future Plans
- 2.8 Alaunos Therapeutics
- 2.8.1 Alaunos Therapeutics Details
- 2.8.2 Alaunos Therapeutics Major Business
- 2.8.3 Alaunos Therapeutics Cell and Gene Therapy Solutions Product and Solutions
- 2.8.4 Alaunos Therapeutics Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Alaunos Therapeutics Recent Developments and Future Plans
- 2.9 Homology Medicines
- 2.9.1 Homology Medicines Details
- 2.9.2 Homology Medicines Major Business
- 2.9.3 Homology Medicines Cell and Gene Therapy Solutions Product and Solutions
- 2.9.4 Homology Medicines Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Homology Medicines Recent Developments and Future Plans
- 2.10 Biogen
- 2.10.1 Biogen Details
- 2.10.2 Biogen Major Business
- 2.10.3 Biogen Cell and Gene Therapy Solutions Product and Solutions
- 2.10.4 Biogen Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Biogen Recent Developments and Future Plans
- 2.11 Legend Biotech
- 2.11.1 Legend Biotech Details
- 2.11.2 Legend Biotech Major Business
- 2.11.3 Legend Biotech Cell and Gene Therapy Solutions Product and Solutions
- 2.11.4 Legend Biotech Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.11.5 Legend Biotech Recent Developments and Future Plans
- 2.12 CARsgen
- 2.12.1 CARsgen Details
- 2.12.2 CARsgen Major Business
- 2.12.3 CARsgen Cell and Gene Therapy Solutions Product and Solutions
- 2.12.4 CARsgen Cell and Gene Therapy Solutions Revenue, Gross Margin and Market Share (2020-2025)
- 2.12.5 CARsgen Recent Developments and Future Plans
- 3 Market Competition, by Players
- 3.1 Global Cell and Gene Therapy Solutions Revenue and Share by Players (2020-2025)
- 3.2 Market Share Analysis (2024)
- 3.2.1 Market Share of Cell and Gene Therapy Solutions by Company Revenue
- 3.2.2 Top 3 Cell and Gene Therapy Solutions Players Market Share in 2024
- 3.2.3 Top 6 Cell and Gene Therapy Solutions Players Market Share in 2024
- 3.3 Cell and Gene Therapy Solutions Market: Overall Company Footprint Analysis
- 3.3.1 Cell and Gene Therapy Solutions Market: Region Footprint
- 3.3.2 Cell and Gene Therapy Solutions Market: Company Product Type Footprint
- 3.3.3 Cell and Gene Therapy Solutions Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
- 4 Market Size Segment by Type
- 4.1 Global Cell and Gene Therapy Solutions Consumption Value and Market Share by Type (2020-2025)
- 4.2 Global Cell and Gene Therapy Solutions Market Forecast by Type (2026-2031)
- 5 Market Size Segment by Application
- 5.1 Global Cell and Gene Therapy Solutions Consumption Value Market Share by Application (2020-2025)
- 5.2 Global Cell and Gene Therapy Solutions Market Forecast by Application (2026-2031)
- 6 North America
- 6.1 North America Cell and Gene Therapy Solutions Consumption Value by Type (2020-2031)
- 6.2 North America Cell and Gene Therapy Solutions Market Size by Application (2020-2031)
- 6.3 North America Cell and Gene Therapy Solutions Market Size by Country
- 6.3.1 North America Cell and Gene Therapy Solutions Consumption Value by Country (2020-2031)
- 6.3.2 United States Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 6.3.3 Canada Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 6.3.4 Mexico Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 7 Europe
- 7.1 Europe Cell and Gene Therapy Solutions Consumption Value by Type (2020-2031)
- 7.2 Europe Cell and Gene Therapy Solutions Consumption Value by Application (2020-2031)
- 7.3 Europe Cell and Gene Therapy Solutions Market Size by Country
- 7.3.1 Europe Cell and Gene Therapy Solutions Consumption Value by Country (2020-2031)
- 7.3.2 Germany Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 7.3.3 France Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 7.3.4 United Kingdom Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 7.3.5 Russia Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 7.3.6 Italy Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 8 Asia-Pacific
- 8.1 Asia-Pacific Cell and Gene Therapy Solutions Consumption Value by Type (2020-2031)
- 8.2 Asia-Pacific Cell and Gene Therapy Solutions Consumption Value by Application (2020-2031)
- 8.3 Asia-Pacific Cell and Gene Therapy Solutions Market Size by Region
- 8.3.1 Asia-Pacific Cell and Gene Therapy Solutions Consumption Value by Region (2020-2031)
- 8.3.2 China Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 8.3.3 Japan Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 8.3.4 South Korea Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 8.3.5 India Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 8.3.6 Southeast Asia Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 8.3.7 Australia Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 9 South America
- 9.1 South America Cell and Gene Therapy Solutions Consumption Value by Type (2020-2031)
- 9.2 South America Cell and Gene Therapy Solutions Consumption Value by Application (2020-2031)
- 9.3 South America Cell and Gene Therapy Solutions Market Size by Country
- 9.3.1 South America Cell and Gene Therapy Solutions Consumption Value by Country (2020-2031)
- 9.3.2 Brazil Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 9.3.3 Argentina Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 10 Middle East & Africa
- 10.1 Middle East & Africa Cell and Gene Therapy Solutions Consumption Value by Type (2020-2031)
- 10.2 Middle East & Africa Cell and Gene Therapy Solutions Consumption Value by Application (2020-2031)
- 10.3 Middle East & Africa Cell and Gene Therapy Solutions Market Size by Country
- 10.3.1 Middle East & Africa Cell and Gene Therapy Solutions Consumption Value by Country (2020-2031)
- 10.3.2 Turkey Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 10.3.3 Saudi Arabia Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 10.3.4 UAE Cell and Gene Therapy Solutions Market Size and Forecast (2020-2031)
- 11 Market Dynamics
- 11.1 Cell and Gene Therapy Solutions Market Drivers
- 11.2 Cell and Gene Therapy Solutions Market Restraints
- 11.3 Cell and Gene Therapy Solutions Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 12 Industry Chain Analysis
- 12.1 Cell and Gene Therapy Solutions Industry Chain
- 12.2 Cell and Gene Therapy Solutions Upstream Analysis
- 12.3 Cell and Gene Therapy Solutions Midstream Analysis
- 12.4 Cell and Gene Therapy Solutions Downstream Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
- 14.3 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook